A pharmaceutical company is formulating a new medication that prevents painful gout attacks. However, the lead researchers are also mindful of its impacts to the human liver, which can be indicated by monitoring levels of alanine aminotransferase- (or ALT, in U/L units). If the ALT levels exceed an average of 55 U/L, there is an indication of the drug having damaging effects to the liver. Let us assume that ALT levels are normally distributed with standard deviation of 15.7 U/L. To determine the consequence of this new drug, they randomly selected 162 adult men with gout and monitored levels of alanine aminotransferase (or ALT, in U/L units) after taking the new medicine for 6 months. From the sample, it is found that the average ALT level is 59 U/L. It is suspected levels are significantly increased. Conduct a test of significance with a=0.05.

MATLAB: An Introduction with Applications
6th Edition
ISBN:9781119256830
Author:Amos Gilat
Publisher:Amos Gilat
Chapter1: Starting With Matlab
Section: Chapter Questions
Problem 1P
icon
Related questions
icon
Concept explainers
Question
A pharmaceutical company is formulating a new medication that prevents painful
gout attacks. However, the lead researchers are also mindful of its impacts to the
human liver, which can be indicated by monitoring levels of alanine aminotransferase
(or ALT, in U/L units). If the ALT levels exceed an average of 55 U/L, there is an
indication of the drug having damaging effects to the liver. Let us assume that ALT
levels are normally distributed with standard deviation of 15.7 U/L.
To determine the consequence of this new drug, they randomly selected 162 adult
men with gout and monitored levels of alanine aminotransferase (or ALT, in U/L
units) after taking the new medicine for 6 months.
From the sample, it is found that the average ALT level is 59 U/L. It is suspected
levels are significantly increased. Conduct a test of significance with a=0.05.
What is your conclusion in the context of the problem?
There is an indication of the new medication having damaging effects to the
human liver as indicated by the significantly decreased ALT levels.
There is an indication of the new medication having damaging effects to the
human liver as indicated by the significantly increased ALT levels.
There is no indication of the new medication having damaging effects to the
human liver as indicated by a lack of sufficient evidence to support significantly
different ALT levels.
At 95% level of significance, there is no indication of the new medication having
damaging effects to the human liver.
There is no indication of the new medication having damaging effects to the
human liver as indicated by a lack of sufficient evidence to support significantly
increased ALT levels.
Transcribed Image Text:A pharmaceutical company is formulating a new medication that prevents painful gout attacks. However, the lead researchers are also mindful of its impacts to the human liver, which can be indicated by monitoring levels of alanine aminotransferase (or ALT, in U/L units). If the ALT levels exceed an average of 55 U/L, there is an indication of the drug having damaging effects to the liver. Let us assume that ALT levels are normally distributed with standard deviation of 15.7 U/L. To determine the consequence of this new drug, they randomly selected 162 adult men with gout and monitored levels of alanine aminotransferase (or ALT, in U/L units) after taking the new medicine for 6 months. From the sample, it is found that the average ALT level is 59 U/L. It is suspected levels are significantly increased. Conduct a test of significance with a=0.05. What is your conclusion in the context of the problem? There is an indication of the new medication having damaging effects to the human liver as indicated by the significantly decreased ALT levels. There is an indication of the new medication having damaging effects to the human liver as indicated by the significantly increased ALT levels. There is no indication of the new medication having damaging effects to the human liver as indicated by a lack of sufficient evidence to support significantly different ALT levels. At 95% level of significance, there is no indication of the new medication having damaging effects to the human liver. There is no indication of the new medication having damaging effects to the human liver as indicated by a lack of sufficient evidence to support significantly increased ALT levels.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 2 steps

Blurred answer
Knowledge Booster
Continuous Probability Distribution
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, statistics and related others by exploring similar questions and additional content below.
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
MATLAB: An Introduction with Applications
MATLAB: An Introduction with Applications
Statistics
ISBN:
9781119256830
Author:
Amos Gilat
Publisher:
John Wiley & Sons Inc
Probability and Statistics for Engineering and th…
Probability and Statistics for Engineering and th…
Statistics
ISBN:
9781305251809
Author:
Jay L. Devore
Publisher:
Cengage Learning
Statistics for The Behavioral Sciences (MindTap C…
Statistics for The Behavioral Sciences (MindTap C…
Statistics
ISBN:
9781305504912
Author:
Frederick J Gravetter, Larry B. Wallnau
Publisher:
Cengage Learning
Elementary Statistics: Picturing the World (7th E…
Elementary Statistics: Picturing the World (7th E…
Statistics
ISBN:
9780134683416
Author:
Ron Larson, Betsy Farber
Publisher:
PEARSON
The Basic Practice of Statistics
The Basic Practice of Statistics
Statistics
ISBN:
9781319042578
Author:
David S. Moore, William I. Notz, Michael A. Fligner
Publisher:
W. H. Freeman
Introduction to the Practice of Statistics
Introduction to the Practice of Statistics
Statistics
ISBN:
9781319013387
Author:
David S. Moore, George P. McCabe, Bruce A. Craig
Publisher:
W. H. Freeman